1,210
Views
47
CrossRef citations to date
0
Altmetric
Research Article

Takayasu Arteritis: Diagnosis, Treatment and Prognosis

, &
Pages 462-473 | Accepted 11 Oct 2012, Published online: 07 Dec 2012

REFERENCES

  • Numano F, Okawara M, Inomata H, Kobayashi Y. Takayasu's arteritis. Lancet. 2000;356(9234): 1023–1025.
  • Arnaud L, Kahn JE, Girszyn N, et al. Takayasu's arteritis: an update on physiopathology. Eur J Intern Med. 2006;17(4):241–246.
  • Rav-Acha M, Plot L, Peled N, Amital H. Coronary involvement in Takayasu's arteritis. Autoimmun Rev. 2007;6(8):566–571.
  • Rathod KR, Deshmukh HL, Garg AI, Spectrum of angiographic findings in aortoarteritis. Clin Radiol. 2005;60(7):746–755.
  • Gargah T, Harrath MB, Bachrouche H, First case of childhood Takayasu arteritis with renal artery aneurysms. Pediatr Rheumatol Online J. 2010;8:21.
  • Arnaud L, Haroche J, Mathian A, Pathogenesis of Takayasu's arteritis: a 2011 update. Autoimmun Rev. 2011;11(1):61–67.
  • Kallenberg CG, Tadema H. Vasculitis and infections: contribution to the issue of autoimmunity reviews devoted to “Autoimmunity and infection.” Autoimmun Rev. 2008;8(1):29–32.
  • Noris M. Pathogenesis of Takayasu's arteritis. J Nephrol. 2001;14(6):506–513.
  • Cooper GS, Miller FW, Pandey JP. The role of genetic factors in autoimmune disease: implications for environmental research. Environ Health Perspect. 1999;107((Suppl 5)):693–700.
  • Kasuya N, Kishi Y, Isobe M, P-selectin expression, but not GPIIb/IIIa activation, is enhanced in the inflammatory stage of Takayasu's arteritis. Circ J. 2006;70(5):600–604.
  • Nityanand S, Giscombe R, Srivastava S, A bias in the alpha, beta-T-cell receptor variable region gene usage in Takayasu's arteritis. Clin Exp Immunol. 1997;107(2):261–268.
  • Dhawan V, Mahajan N, Jain S. Role of C-C chemokines in Takayasu's arteritis disease. Int J Cardiol. 2006;112(1):105–111.
  • Dhar J, Ganguly NK, Kumari S, Sharma BK. Role of calcium and protein kinase C in the activation of T cells in Takayasu's arteritis. Jpn Heart J. 1995;36(3):341–348.
  • Seko Y, Sato O, Takagi A, Restricted usage of T-cell receptor Valpha-Vbeta genes in infiltrating cells in aortic tissue of patients with Takayasu's arteritis. Circulation. 1996;93(10):1788–1790.
  • Seko Y. Giant cell and Takayasu arteritis. Curr Opin Rheumatol. 2007;19(1):39–43.
  • Noris M, Daina E, Gamba S, Interleukin-6 and RANTES in Takayasu arteritis: a guide for therapeutic decisions? Circulation. 1999;100(1):55–60.
  • Mahajan N, Dhawan V, Malik S, Jain S. Implication of oxidative stress and its correlation with activity of matrix metalloproteinases in patients with Takayasu's arteritis disease. Int J Cardiol. 2010;145(2):286–288.
  • Numano F, Kishi Y, Tanaka A, Inflammation and atherosclerosis: atherosclerosis lesions in Takayasu arteritis. Ann NY Acad Sci. 2000;902:65–76.
  • Seyahi E, Ugurlu S, Cumali R, Atherosclerosis in Takayasu arteritis. Ann Rheum Dis. 2006;65(9):1202–1207.
  • de Souza AW, Ataíde Mariz H, Torres Reis Neto E, Risk factors for cardiovascular disease and endothelin-1 levels in Takayasu arteritis patients. Clin Rheumatol. 2009;28(4):379–383.
  • Isohisa I, Numano F, Maezawa H, Sasazuki T. HLA-Bw52 in Takayasu disease. Tissue Antigens. 1978;12(4):246–248.
  • Park MH, Park YB. HLA typing of Takayasu arteritis in Korea. Heart Vessels Suppl. 1992;7:81–84.
  • Kitamura H, Kobayashi Y, Kimura A, Numano F. Association of clinical manifestations with HLA-B alleles in Takayasu arteritis. Int J Cardiol. 1998;66(Suppl 1):S121–S126.
  • Soto ME, Vargas-Alarcón G, Cicero-Sabido R, Comparison distribution of HLA-B alleles in Mexican patients with Takayasu arteritis and tuberculosis. Hum Immunol. 2007;68(5):449–453.
  • Khraishi MM, Gladman DD, Dagenais P, HLA antigens in North American patients with Takayasu arteritis. Arthritis Rheum. 1992;35(5):573–575.
  • Numano F, Ohta N, Sasazuki T. HLA and clinical manifestations in Takayasu disease. Jpn Circ J. 1982;46(2):184–189.
  • Kasuya K, Hashimoto Y, Numano F. Left ventricular dysfunction and HLA Bw52 antigen in Takayasu arteritis. Heart Vessels Suppl. 1992;7:116–119.
  • Saruhan-Direskeneli G, Biçakçigil M, Yilmaz V, Interleukin (IL)-12, IL-2, and IL-6 gene polymorphisms in Takayasu's arteritis from Turkey. Hum Immunol. 2006;67(9):735–740.
  • Johnston SL, Lock RJ, Gompels MM. Takayasu arteritis: a review. J Clin Pathol. 2002;55(7):481–486.
  • Ueno A, Awane Y, Wakabayachi A, Shimizu K. Successfully operated obliterative brachiocephalic arteritis (Takayasu) associated with the elongated coarctation. Jpn Heart J. l967;8(5):538–544.
  • Lupi-Herrera E, Sánchez-Torres G, Marcushamer J, Takayasu arteritis. Clinical study of 107 cases. Am Heart J. 1977;93(1):94–103.
  • Hata A, Noda M, Moriwaki R, Numano F. Angiographic findings of Takayasu arteritis: new classification. Int J Cardiol. 1996;54(Suppl):S155–S163.
  • Cong XL, Dai SM, Feng X, Takayasu's arteritis: clinical features and outcomes of 125 patients in China. Clin Rheumatol. 2010;29(9):973–981.
  • Gotway MB, Araoz PA, Macedo TA, Imaging findings in Takayasu's arteritis. AJR Am J Roentgenol. 2005;184(6):1945–1950.
  • Mavrogeni S, Dimitroulas T, Chatziioannou SN, Kitas G. The role of multimodality imaging in the evaluation of Takayasu arteritis. Semin Arthritis Rheum. 2012. [Epub ahead of print].
  • Kerr GS, Hallahan CW, Giordano J, Takayasu arteritis. Ann Intern Med. 1994;120(11):919–929.
  • Tezuka D, Haraguchi G, Ishihara T, Role of FDG PET-CT in Takayasu arteritis: sensitive detection of recurrences. JACC Cardiovasc Imaging. 2012;5(4):422–429.
  • Maksimowicz-Mckinnon K, Clark TM, Hoffman GS. Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients. Arthritis Rheum. 2007;56(3):1000–1009.
  • Hoffman GS, Merkel PA, Brasington RD, Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis. Arthritis Rheum. 2004;50(7):2296–2304.
  • Hoffman GS, Ahmed AE. Surrogate markers of disease activity in patients with Takayasu arteritis. A preliminary report from the international network for the study of the systemic vasculitides (INSSYS). Int J Cardiol. 1998;66(Suppl 1):S191–S194.
  • Matsuyama A, Sakai N, Ishigami M, Matrix metalloproteinases as novel disease markers in Takayasu arteritis. Circulation. 2003;108(12):1469–1473.
  • Sharma BK, Jain S, Bali HK, A follow-up study of balloon angioplasty and de-novo stenting in Takayasu arteritis. Int J Cardiol. 2000;75(Suppl 1):S147–S152.
  • Andrews J, Mason JC. Takayasu′s arteritis-recent advances in imaging offer promise. Rheumatology. 2007;46(1):6–15.
  • Villa I, Agudo Bilbao M, Martínez-Taboada VM. Advances in the diagnosis of large vessel vasculitis: identification of biomarkers and imaging studies. Reumatol Clin. 2011;60((Suppl 3)): S22–S27.
  • Borg FA, Dasgupta B. Treatment and outcomes of large vessel arteritis. Best Pract Res Clin Rheumatol. 2009;23(3):325–337.
  • Pipitone N, Versari A, Salvarani C. Role of imaging studies in the diagnosis and follow-up of large-vessel vasculitis: an update. Rheumatology. 2008;47(4):403–408.
  • Chung JW, Kim HC, Choi YH, Patterns of aortic involvement in Takayasu arteritis and its clinical implications: evaluation with spiral computed tomography angiography. J Vasc Surg. 2007;45(5):906–914.
  • Desai MY, Stone JH, Foo TK, Delayed contrast-enhanced MRI of the aortic wall in takayasu's arteritis: initial experience. AJR Am J Roentgenol. 2005;184(5):1427–1431.
  • Kissin EY, Merkel PA. Diagnostic imaging in takayasu arteritis. Curr Opin Rheum. 2004;16(1):31–37.
  • Schmidt WA, Blockmans D. Use of ultrasonography and position emission tomography in the diagnosis of large-vessel vasculitis. Curr Opin Rheumatol. 2005;17(1):9–15.
  • Steeds RP, Mohiaddin R. Takayasu arteritis: role of cardiovascular magnetic imaging. Int J Cardiol. 2006;109(1):1–6.
  • Andrews J, Al-Nahhas A, Pennell DJ, Non-invasive imaging in the diagnosis and management of Takayasu's arteritis. Ann Rheum Dis. 2004;63(8):995–1000.
  • Meller J, Grabbe E, Becker W, Vosshenrich R. Value of F-18 FDG hybrid camera PET and MRI in early Takayasu arteritis. Eur Radiol. 2003;13(2):400–405.
  • Tatsumi M, Cohade C, Nakamoto Y, Wahl RL. Fluorodeoxyglucose uptake in the aortic wall at PET/CT: possible finding for active atherosclerosis. Radiology. 2003;229(3):831–837.
  • Umekita K, Takajo I, Miyauchi S, [18F]fluorodeoxyglucose positron emission tomography is a useful tool to diagnose the early stage of Takayasu's arteritis and to evaluate the activity of the disease. Mod Rheumatol. 2006;16(4):243–247.
  • Arend WP, Michel BA, Bloch DA, The American college of rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum. 1990;33(8):1129–1134.
  • Sharma BK, Jain S, Suri S, Numano F. Diagnostic criteria for Takayasu arteritis. Int J Cardiol. 1996;54(Suppl):S141–S147.
  • Sharma S, Saxena A, Talwar KK, Renal artery stenosis caused by nonspecific arteritis (Takayasu disease): results of treatment with percutaneous transluminal angioplasty. AJR Am J Roentgenol. 1992;158(2):417–422.
  • Seibel S, Gaa J, Küchle C, Frank H. Severe renovascular hypertension in apatient with Takayasu arteritis. Am J Kidney Dis. 2010;56(3):595–598.
  • Yun M, Yeh D, Araujo LI, F-18 FDG uptake in the large arteries: a new observation. Clin Nucl Med. 2001;26:314–319.
  • Maffei S, Di Renzo M, Santoro S, Refractory Takayasu arteritis successfully treated with infliximab. Eur Rev Med Pharmacol Sci. 2009;13(1):63–65.
  • Nunes G, Neves FS, Melo FM, Takayasu arteritis: anti-TNF therapy in a Brazilian setting. Rev Bras Reumatol. 2010;50(3):291–298.
  • Saxena A, Kothari SS, Sharma S, Percutaneous transluminal angioplasty of the aorta in children with nonspecific aortoarteritis: acute and follow-up results with special emphasis on left ventricular function. Catheter Cardiovasc Interv. 2000;49(4):419–424.
  • Fields CE, Bower TC, Cooper LT, Takayasu's arteritis: operative results and influence of disease activity. J Vasc Surg. 2006;43(1):64–71.
  • Liang P, Hoffman GS. Advances in the medical and surgical treatment of Takayasu arteritis. Curr Opin Rheumatol. 2005;17(1):16–24.
  • Ishikawa K, Maetani S. Long-term outcome for 120 Japanese patients with Takayasu's disease. Clinical and statistical analyses of related prognostic factors. Circulation. 1994;90(4):1855–1860.
  • Miyata T, Sato O, Koyama H, Long-term survival after surgical treatment of patients with Takayasu's arteritis. Circulation. 2003;108(12):1474–1480.
  • Endo M, Tomizawa Y, Nishida H, Angiographic findings and surgical treatments of coronary artery involvement in Takayasu arteritis. J Thorac Cardiovasc Surg. 2003;125(3):570–577.
  • Novick AC, Ziegelbaum M, Vidt DG, Trends in surgical revascularization for renal artery disease. Ten years’ experience. JAMA. 1987;257(4):498–501.
  • Miller GA, Ford KK, Braun SD, Percutaneous transluminal angioplasty vs. surgery for renovascular hypertension. Am J Roentgenol. 1985;144(3):447–450.
  • Subramanyan R, Joy J, Balakrishnan KG. Natural history of aortoarteritis (Takayasu's disease). Circulation. 1989;80(3):429–437.
  • Freitas DS, Camargo CZ, Mariz HA, Takayasu arteritis: assessment of response to medical therapy based on clinical activity criteria and imaging techniques. Rheumatol Int. 2012;32(3):703–709.
  • Park MC, Lee SW, Park YB, Clinical characteristics and outcomes of Takayasu's arteritis: analysis of 108 patients using standardized criteria for diagnosis, activity assessment, and angiographic classification. Scand J Rheumatol. 2005;34(4):284–292.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.